Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity

Journal of Allergy and Clinical Immunology: In Practice

Volumn 4, Issue 4, 2016, Pages 665-670

  Divekar, Rohit ^a   Hagan, John ^a   Rank, Matthew ^b   Park, Miguel ^a   Volcheck, Gerald ^a   O'Brien, Erin ^a   Meeusen, Jeffrey ^a   Kita, Hirohito ^a   Butterfield, Joseph ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

AERD; Aspirin; Diagnostic; Leukotriene; LTE4; Predictive; Rhinosinusitis; Sensitivity; Specificity; Urinary

Indexed keywords

LEUKOTRIENE E4; ACETYLSALICYLIC ACID; BIOLOGICAL MARKER;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASPIRIN SENSITIVITY; ASTHMA; CHRONIC RHINOSINUSITIS; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; PREDICTIVE VALUE; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINARY EXCRETION; URINE; ADOLESCENT; CHRONIC DISEASE; MIDDLE AGED; NASAL POLYPS; RHINITIS; SINUSITIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; ASTHMA; BIOMARKERS; CHRONIC DISEASE; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; LEUKOTRIENE E4; MALE; MIDDLE AGED; NASAL POLYPS; RHINITIS; SINUSITIS; YOUNG ADULT;

EID: 84964403031     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2016.03.004     Document Type: Article

References (26)

1. Borish, L., Chronic rhinosinusitis: more than just “asthma of the upper airway”. Am J Respir Crit Care Med 192 (2015), 647–648.
2. Laidlaw, T.M., How patient experiences should change our approach to treating patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract 3 (2015), 719–720.
3. Chang, J.E., White, A., Simon, R.A., Stevenson, D.D., Aspirin-exacerbated respiratory disease: burden of disease. Allergy Asthma Proc 33 (2012), 117–121.
4. Divekar, R., Patel, N., Jin, J., Hagan, J., Rank, M., Lal, D., et al. Symptom-based clustering in chronic rhinosinusitis relates to history of aspirin sensitivity and postsurgical outcomes. J Allergy Clin Immunol Pract 3 (2015), 934–940.e3.
5. Ta, V., White, A.A., Survey-defined patient experiences with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract 3 (2015), 711–718.
6. Shaker, M., Lobb, A., Jenkins, P., O'Rourke, D., Takemoto, S.K., Sheth, S., et al. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 121 (2008), 81–87.
7. Mascia, K., Haselkorn, T., Deniz, Y.M., Miller, D.P., Bleecker, E.R., Borish, L., Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol 116 (2005), 970–975.
8. Szefler, S.J., Wenzel, S., Brown, R., Erzurum, S.C., Fahy, J.V., Hamilton, R.G., et al. Asthma outcomes: biomarkers. J Allergy Clin Immunol 129 (2012), S9–S23.
9. Lee, C.W., Lewis, R.A., Corey, E.J., Austen, K.F., Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes. Immunology 48 (1983), 27–35.
10. Laidlaw, T.M., Kidder, M.S., Bhattacharyya, N., Xing, W., Shen, S., Milne, G.L., et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood 119 (2012), 3790–3798.
11. Celejewska-Wojcik, N., Mastalerz, L., Wojcik, K., Nieckarz, R., Januszek, R., Hartwich, P., et al. Incidence of aspirin hypersensitivity in patients with chronic rhinosinusitis and diagnostic value of urinary leukotriene E4. Pol Arch Med Wewn 122 (2012), 422–427.
12. Israel, E., Fischer, A.R., Rosenberg, M.A., Lilly, C.M., Callery, J.C., Shapiro, J., et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 148 (1993), 1447–1451.
13. Yamaguchi, H., Higashi, N., Mita, H., Ono, E., Komase, Y., Nakagawa, T., et al. Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma. Clin Exp Allergy 41 (2011), 1711–1718.
14. Asano, K., Lilly, C.M., O'Donnell, W.J., Israel, E., Fischer, A., Ransil, B.J., et al. Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma. J Allergy Clin Immunol 96 (1995), 643–651.
15. Sanak, M., Bochenek, G., Faber, J., Plutecka, H., Szczeklik, A., Elevated urinary leukotriene E excretion in asthma: a comparison of HPLC-mass spectrometry and ELISA. Allergy 65 (2010), 663–664.
16. Micheletto, C., Visconti, M., Tognella, S., Facchini, F.M., Dal Negro, R.W., Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls. Eur Ann Allergy Clin Immunol 38 (2006), 20–23.
17. Swierczynska-Krepa, M., Sanak, M., Bochenek, G., Strek, P., Cmiel, A., Gielicz, A., et al. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study. J Allergy Clin Immunol 134 (2014), 883–890.
18. Bancalari, L., Conti, I., Giannessi, D., Lazzerini, G., Dente, F.L., De Caterina, R., et al. Early increase in urinary leukotriene E4 (LTE4) is dependent on allergen dose inhaled during bronchial challenge in asthmatic subjects. Allergy 54 (1999), 1278–1285.
19. Green, S.A., Malice, M.P., Tanaka, W., Tozzi, C.A., Reiss, T.F., Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation. Thorax 59 (2004), 100–104.
20. Duffield-Lillico, A.J., Boyle, J.O., Zhou, X.K., Ghosh, A., Butala, G.S., Subbaramaiah, K., et al. Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res 2 (2009), 322–329.
21. Westcott, J.Y., Maxey, K.M., MacDonald, J., Wenzel, S.E., Immunoaffinity resin for purification of urinary leukotriene E4. Prostaglandins Other Lipid Mediat 55 (1998), 301–321.
22. Glas, A.S., Lijmer, J.G., Prins, M.H., Bonsel, G.J., Bossuyt, P.M., The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56 (2003), 1129–1135.
23. Chiu, C.Y., Tsai, M.H., Yao, T.C., Tu, Y.L., Hua, M.C., Yeh, K.W., et al. Urinary LTE4 levels as a diagnostic marker for IgE-mediated asthma in preschool children: a birth cohort study. PLoS One, 9, 2014, e115216.
24. Butterfield, J.H., Increased leukotriene E4 excretion in systemic mastocytosis. Prostaglandins Other Lipid Mediat 92 (2010), 73–76.
25. Raithel, M., Zopf, Y., Kimpel, S., Naegel, A., Molderings, G.J., Buchwald, F., et al. The measurement of leukotrienes in urine as diagnostic option in systemic mastocytosis. J Physiol Pharmacol 62 (2011), 469–472.
26. Ledford, D.K., Wenzel, S.E., Lockey, R.F., Aspirin or other nonsteroidal inflammatory agent exacerbated asthma. J Allergy Clin Immunol Pract 2 (2014), 653–657.